Group structure
3 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELTROMBOPAG OLAMINE12.5mg acid/packet | 25mg acid/packet · For suspension | Eltrombopag | United States | Marketed | 2024 |
| EPLERENONE25mg | 50mg · Tablet | Eplerenone | United States | Marketed | 2008 |
| FLUVOXAMINE MALEATE100mg | 150mg · Capsule, extended release | Fluvoxamine | United States | Marketed | 2013 |
| ITRACONAZOLE10mg/ml · Solution | Itraconazole | United States | Marketed | 2015 |
| L-GLUTAMINE5gm/packet · For solution | L-glutamine | United States | Marketed | 2024 |
| METFORMIN HYDROCHLORIDE500mg/5ml · Solution | Metformin | United States | Marketed | 2020 |
| NITAZOXANIDE500mg · Tablet | Nitazoxanida | United States | Marketed | 2020 |
| PANTOPRAZOLE SODIUM40mg base · For suspension, delayed release | Pantoprazole | United States | Marketed | 2020 |
| SAPROPTERIN DIHYDROCHLORIDE100mg · Tablet | Sapropterin | United States | Marketed | 2019 |
| EMPAGLIFLOZIN; LINAGLIPTIN10mg; 5mg | 10mg/5mg | 25mg; 5mg | 25mg/5mg · Tablet | Empagliflozin, Linagliptin | United States | tentative | 2020 |
| GABAPENTIN ENACARBIL600mg · Tablet, extended release | Gabapentin enacarbil | United States | tentative | 2026 |
| TOFACITINIB10mg | 5mg · Tablet | Tofacitinib | United States | tentative | 2024 |